台股 » 個股 » 易威 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

易威

(1799)
  • 股價
    61.6
  • 漲跌
    ▲0.7
  • 漲幅
    +1.15%
  • 成交量
    265
  • 產業
    上櫃 生技醫療類股
  • 69人加入追蹤

    立即追蹤

  • 本地時間:13:30(已收盤)

     
易威 (1799)籌碼相關-富邦 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

富邦 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/12/2600.000.170.1066.60-0.1692-0.01%
2024/12/250.176.80975.1074.00-8.9683-1.31%
2024/12/24973.00470.0073.0056770.74%
2024/12/23466.4000.0066.4046800.59%
2024/12/20261.0000.0060.4026840.29%
2024/12/1300.00154.3054.90-1678-0.15%
2024/12/12155.2000.0054.9016780.15%
2024/12/1100.0013454.9254.90-134666-20.11% 大賣/鉅額交易
2024/12/0400.00367.8067.00-3655-0.46%
2024/12/0300.00167.0067.80-1662-0.15%
2024/12/02467.3000.0066.6046630.60%
2024/11/2600.00168.9068.60-1681-0.15%
2024/11/22171.7000.0073.0016720.15%
2024/11/2100.00167.0068.00-1662-0.15%
2024/11/20168.8000.0067.4016660.15%
2024/11/1500.00171.4066.00-1678-0.15%
2024/11/1400.0011064.5969.00-110670-16.40% 大賣/鉅額交易
2024/11/12166.6000.0070.0016320.16%
2024/11/0400.00590.1291.80-5637-0.78%
2024/10/2200.001108.50107.00-1726-0.14%
2024/10/211106.0000.00105.5017360.14%
2024/10/1100.000117.00114.5008240.00%
2024/10/0800.003122.00126.00-3839-0.36%
2024/10/071.1116.8430110.25116.50-28.9830-3.47%
2024/10/042106.500.1106.50106.5028130.24%
2024/10/010.1100.0000.0097.200.17870.01%
2024/09/300108.0071109.19108.00-71777-9.13%
2024/09/272120.50111122.30120.00-109796-13.68% 大賣/鉅額交易
2024/09/0400.007209.14207.00-7802-0.87%
2024/08/3050221.9800.00216.00507926.31%
2024/08/2952216.6800.00221.00527956.54%
2024/08/2800.007212.50210.00-7788-0.89%
2024/08/2200.000.1223.00221.50-0.1798-0.01%
2024/08/210227.0012222.00225.00-12802-1.49%
2024/08/200218.0000.00216.0008060.00%
2024/08/190202.5000.00201.5008200.00%
2024/08/167199.000197.00200.5078220.85%
2024/08/150193.0000.00191.5008270.00%
2024/08/1412195.000190.50192.00128411.42%
2024/08/1310194.100191.00189.00108431.18%
2024/08/09163200.860202.00203.5016382419.78% 大買/鉅額交易
2024/08/080185.508187.31187.00-8794-1.00%
2024/08/070178.0000.00180.0007810.00%
2024/08/0633176.1400.00171.00337774.25%
2024/07/305149.5000.00148.0057160.70%
2024/07/260157.000158.00148.0007000.00%
2024/07/2200.0010164.40164.00-10667-1.50%
2024/07/1898194.550195.50196.509861116.04%
2024/07/170174.5000.00191.0005890.00%
2024/07/164172.004165.00174.5005660.00%
2024/07/121161.5100.00162.0015440.19%
2024/07/110155.001154.00149.00-1531-0.19%
2024/07/101152.501152.50152.5005120.00%
2024/07/095139.5000.00139.0054991.00%
2024/07/040128.0000.00126.0004770.00%
2024/07/0100.004129.50137.50-4435-0.92%
2024/06/284130.0000.00130.0044130.97%
2024/06/1800.004104.00104.50-4364-1.10%
2024/06/174108.0000.00108.0043531.13%
2024/06/1200.001097.6997.40-10327-3.05%
2024/06/0600.001095.2195.00-10318-3.14%
2024/05/3100.001092.4591.80-10317-3.15%
2024/05/30593.802591.4490.90-20320-6.24%
2024/05/2400.001499.01105.00-14298-4.69%
2024/05/233998.6700.00100.503928613.61%
2024/05/222595.0000.0091.50252609.58%
易威慢性心臟衰竭用藥獲中國藥證 明年Q1底展開銷售Anue鉅亨-2023/10/30
美新行政令強化製藥在地化 易威、泰福-KY迎來新訂單Anue鉅亨-2022/09/20
〈易威法說〉策略轉型見成效 新藥、學名藥營收比重拚達7成Anue鉅亨-2021/12/17
易威 相關文章
易威 相關影音